Funding for this research was provided by:
Novartis Pharmaceuticals UK Limited
Medical Research Council (MR/R014019/1)
Wellcome Trust (294834/Z/16/Z)
Received: 22 September 2021
Accepted: 12 October 2021
First Online: 11 November 2021
: The study was approved by London – Harrow Research Ethics Committee (REC reference 18/LO/0745) on 10 July 2018. Written informed consent will be obtained for all participants or the professional or personal representative.
: The authors are willing to provide a model consent form on request.
: The authors declare that they have no competing interests.